Beta Drugs Ltd.
BSE: 535022 | Sector: Health care |
NSE: BETA | ISIN Code: INE351Y01019 |
BSE 05:30 | 01 Jan | Beta Drugs Ltd |
NSE 00:00 | 24 Jun | 609.70 |
-0.85 (-0.14%) |
OPEN
657.50 |
HIGH
657.50 |
LOW
605.30 |
OPEN | |
PREVIOUS CLOSE | |
VOLUME | |
52-Week high | 0.00 |
52-Week low | 0.00 |
P/E | |
Mkt Cap.(Rs cr) | 0 |
Buy Price | |
Buy Qty | |
Sell Price | |
Sell Qty |
Beta Drugs Ltd. (BETA) - BULK DEALS
DATE | CLIENT NAME | EXCHANGE | TRANSACTION | QUANTITY | PRICE |
01-09-2020 | BATRA VIJAY KUMAR | NSE | BUY | 50400 | 84.95 |
24-07-2020 | ADESH VENTURES LLP | NSE | SELL | 108000 | 95.52 |
24-07-2020 | ONKAR SINGH | NSE | BUY | 87200 | 96.03 |
29-11-2018 | BATRA VIJAY KUMAR | NSE | BUY | 48800 | 73.25 |
29-10-2018 | SACHIN KASERA | NSE | BUY | 50400 | 70.00 |
29-10-2018 |
VALUEWORTH CAPITAL MANAGEMENT PVT LTD |
NSE | SELL | 52000 | 70.06 |
23-07-2018 |
VORA FINANCIAL SERVICES PRIVATELIMI TED |
NSE | SELL | 51200 | 90.14 |
17-10-2017 | SHATRUNJAY INVESTMENTS | NSE | SELL | 49600 | 96.27 |
17-10-2017 | V N SHAH | NSE | SELL | 51200 | 95.71 |
13-10-2017 | NARENDER MOHAN GUPTA | NSE | BUY | 65600 | 104.42 |
13-10-2017 | JAYNEEL SECURITIES PRIVATE LIMITED | NSE | BUY | 44800 | 107.25 |
13-10-2017 | K S SHAH | NSE | SELL | 49600 | 104.55 |
13-10-2017 | JAYNEEL SECURITIES PRIVATE LIMITED | NSE | SELL | 44800 | 107.61 |
13-10-2017 | K S SHAH | NSE | BUY | 8000 | 103.85 |
13-10-2017 | NARENDER MOHAN GUPTA | NSE | SELL | 1600 | 106.60 |
13-10-2017 | JOSEPH ANTONY | NSE | SELL | 44800 | 107.38 |
12-10-2017 | SHATRUNJAY INVESTMENTS | NSE | BUY | 49600 | 102.00 |
12-10-2017 | VARSHNEY ALPNA | NSE | BUY | 44800 | 101.83 |
12-10-2017 | GARNET INTERNATIONAL LIMITED | NSE | SELL | 94400 | 102.00 |
12-10-2017 | SUMAN P SABOO | NSE | SELL | 64000 | 102.00 |
Quick Links for Beta Drugs:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices